What Metro Vein Centers does

Metro Vein Centers is a private, direct-to-consumer healthcare provider founded in 2008 and headquartered in New York, specializing in the diagnosis and minimally invasive treatment of chronic venous insufficiency, varicose veins, and spider veins. The company operates 72 owned-and-operated clinic locations across 8 U.S. states (New York, New Jersey, Michigan, Connecticut, Texas, Arizona, Illinois, and Pennsylvania), staffed by board-certified vein specialists, vascular surgeons, and physicians holding credentials such as DABVLM, RPVI, and ABIM certification. Its clinical offering comprises eight FDA-approved treatment modalities, including radiofrequency ablation, endovenous laser ablation, sclerotherapy, Varithena microfoam, VenaSeal adhesive closure, microphlebectomy, Excel V+ laser, and compression therapy, all delivered as outpatient procedures typically completed in under 30 minutes with minimal downtime.

The business model is built on fee-for-service medical procedures reimbursed primarily through health insurance, with the company accepting 200+ insurance plans and reporting that over 91% of vein treatments are covered by insurance. A secondary self-pay revenue stream exists for cosmetic spider vein treatments priced at $350 per session. Patient acquisition relies on a DTC marketing stack combining content marketing (The Vein Blog), local SEO, a free online Vein Health Quiz, patient referral programs, and earned media in outlets such as Good Housekeeping and Woman's Day. The company reports 100,000+ patients treated cumulatively, 98% patient satisfaction, and 16,000+ five-star reviews.

Free vein evaluations at all locations serve as the primary lead-conversion mechanism, with bookings flowing through website consults, a central phone line (888-660-3494), and individual clinic phone numbers. The company has no disclosed parent, private equity sponsor, or institutional investor, and no funding rounds, acquisitions, or M&A activity are documented. Recent strategic activity has focused on geographic expansion (entry into Illinois), regulatory credentialing (IAC accreditations at Trevose, Tucson, and Pennsylvania), and multi-state clinic densification, particularly in Texas.

Name

Metro Vein Centers

Legal name

Metro Vein Centers

Website

https://metroveincenters.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

51–100 employees

Short description

Metro Vein Centers is a private multi-state healthcare provider operating 72 owned clinics across 8 U.S. states, delivering FDA-approved minimally invasive treatments for varicose veins, spider veins, and chronic venous insufficiency to individual patients via insurance reimbursement and self-pay.

Ownership category

akta.pro rank

Product category

Vein Treatment Services

NAICS

Offices of Physicians (62111), Offices of Physicians (except Mental Health Specialists) (621111), Ambulatory Health Care Services (621)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)

akta.pro primary industry

Vascular Medicine (Peripheral Arterial/Venous Disease) (HLAKABAG)

Keywords

• Vein treatment services
• Varicose vein care
• Spider vein removal
• Vascular surgery services
• Minimally invasive procedures

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices8 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain, Technology or R&D

Revenue model

1. Medical procedure fees (insurance-reimbursed): The primary revenue stream is fee-for-service medical procedures for varicose vein and spider vein treatments. Varicose vein treatments are typically covered by insurance as medically necessary procedures. The company accepts over 200 insurance plans and bills insurance directly. Over 91% of vein treatments are covered by insurance.
2. Self-pay / cosmetic procedures: Spider vein treatments that are deemed purely cosmetic (without associated medical symptoms) are typically not covered by insurance and are paid out-of-pocket by patients. Metro Vein Centers offers sclerotherapy at $350 per session and laser treatments at $350 per session, with discounted pricing for multiple treatments.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Metro Vein Centers is a healthcare provider operating 72 owned clinic locations across 8 U.S. states, specializing in minimally invasive, FDA-approved treatments for varicose veins, spider veins, and chronic venous insufficiency. The company delivers an integrated portfolio of vein care modalities—including radiofrequency ablation, endovenous laser ablation, sclerotherapy, Varithena, VenaSeal, microphlebectomy, and Excel V+ laser—performed in-office by board-certified vein specialists. Services are billed primarily through insurance reimbursement (200+ accepted plans), with self-pay options for cosmetic spider vein treatments.

Product overview

Metro Vein Centers is a healthcare provider offering a unified portfolio of minimally invasive, FDA-approved vein treatments for varicose veins, spider veins, and chronic venous insufficiency. The core offering consists of eight distinct treatment modalities: Radiofrequency Ablation and Endovenous Laser Ablation (thermal ablation treatments using heat from radio waves and lasers respectively), Sclerotherapy and Varithena (injectable chemical foam treatments), VenaSeal (injectable medical-grade adhesive), Microphlebectomy (surgical removal via tiny incisions), Compression Therapy (supportive home care), and excel V+ Laser (non-invasive laser light treatment). All treatments are outpatient procedures typically lasting under 30 minutes with minimal downtime, performed by board-certified vein specialists at nationally accredited clinics across 8 states.

Differentiator

Problem solved

Functional benefit

Products and services

• Radiofrequency Ablation A vein treatment using heat from radio waves to close problematic veins. FDA-approved, minimally invasive, performed in-office in less than 30 minutes with minimal downtime. Targeted at adults with symptomatic varicose veins and chronic venous insufficiency.
• Sclerotherapy A vein treatment using an injectable solution or foam medication to close spider veins and smaller varicose veins. Each session lasts approximately 15 minutes. Typically self-pay at $350 per session, with volume discounts for multiple treatments.
• Varithena A vein treatment using an FDA-approved injectable microfoam medication to treat spider and varicose veins, particularly those in deeper veins beneath the skin surface.
• Endovenous Laser Ablation A vein treatment (EVLA) using heat from a laser to close larger, problematic varicose veins under ultrasound guidance and local anesthesia. Minimally invasive, performed in under 30 minutes.
• Microphlebectomy A vein treatment using tiny 2-3mm incisions to remove bulging varicose veins from the surface of the legs. No stitches required and minimal scarring.
• VenaSeal A vein treatment using an injectable medical-grade bioadhesive to close diseased veins. Requires only one injection per vein, with a 99% success rate at six months per cited data.
• Excel V+ Laser A 100% non-invasive vein treatment using pulsed light from a laser for spider vein elimination without incisions or injections. Self-pay at $350 per session.
• Free Vein Evaluation A complimentary initial vein health consultation offered at all 72 clinic locations. Includes physical exam, medical history review, and potentially ultrasound diagnostics to assess patient candidacy for treatment.
• Compression Therapy Supportive care using compression stockings/garments to manage vein health at home, improve circulation, reduce swelling, and support post-treatment recovery.

Quantifiable outcome

• 98% patient satisfaction rate across Metro Vein Centers network
• +5 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• USA Vein Clinics: One of the largest U.S. networks dedicated exclusively to outpatient vein treatment, operating a multi-state clinic footprint with a similar mix of RFA, EVLA, sclerotherapy, VenaSeal, and Varithena procedures and direct-to-patient acquisition.
• Center for Vein Restoration: Multi-state physician-led vein care practice offering the same core minimally invasive modalities (RFA, EVLA, sclerotherapy, VenaSeal, Varithena) for chronic venous insufficiency, with comparable insurance-driven revenue model and DTC marketing.
• Alpha Vein Clinic: Outpatient vein treatment clinic offering RFA, EVLA, sclerotherapy, and VenaSeal to varicose vein patients with insurance-driven pricing, competing directly for the same patient demographic.
• Vein Institute of Pinellas / Vein Institute locations: Network of vein-focused outpatient clinics providing minimally invasive varicose and spider vein treatments using the same FDA-approved modalities, targeting the same insurance-reimbursed patient base.
• NJ Vein Care / NJ Cardiovascular: Multi-specialty vascular group offering outpatient vein treatment alongside broader cardiovascular services in the Northeast, directly competing for insured vein patients in overlapping geographies.
• American Vein & Vascular Institute: Multi-site vein and vascular specialty provider with comparable procedure mix and physician-led care model, competing in adjacent U.S. markets for insured venous insufficiency patients.
• Total Vein & Vascular: Regional vein and vascular specialty practice offering endovenous ablation, sclerotherapy, and related minimally invasive procedures, directly competing for insured and self-pay vein patients.

Regional players

• Vein & Vascular Institute: Regional vein and vascular specialist group with multiple clinic locations offering similar minimally invasive venous treatments under a comparable insurance-accepted, board-certified physician model.
• Miami Vein Center: Florida-based vein specialty practice offering the same minimally invasive treatment portfolio and DTC-led acquisition model, primarily competing in a different geography.

Broad incumbents

• Vital Heart & Vein: Broader cardiology and vascular practice that includes outpatient vein treatment among its services, overlapping with Metro Vein Centers on procedure offerings but operating a wider cardiovascular scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/metrovein
• Facebookfacebook.com/MetroVein

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Metro Vein Centers